King of Prussia, PA, United States of America

Peng Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2011 - 2019)
  • Collegeville, PA (US) (2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations and Contributions of Inventor Peng Li

Introduction

Peng Li is a notable inventor based in King of Prussia, Pennsylvania. He holds three patents that reflect his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents, one is titled "TRPV4 antagonists." This invention relates to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them, and their use as TRPV4 antagonists. Another significant patent is "Biaryl pyrazoles as NRF2 regulators." This invention involves biaryl pyrazole compounds of Formula (I), methods of making them, pharmaceutical compositions containing them, and their use as NRF2 regulators.

Career Highlights

Peng Li has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline Intellectual Property Development Limited and Astex Therapeutics Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Joseph E Pero and James Francis Callahan. Their collaborations have likely enhanced the research and development efforts in which Peng Li has been involved.

Conclusion

Peng Li's innovative work and patents demonstrate his commitment to advancing pharmaceutical science. His contributions are valuable to the field and highlight the importance of research and collaboration in developing new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…